The macrophage stimulating protein/Ron pathway as a potential therapeutic target to impede multiple mechanisms

Kelsi L Kretschmann1, Henok Eyob, Saundra S Buys

  • 1Department of Oncological Sciences, University of Utah, Salt Lake City, UT 84112, USA.

Current Drug Targets
|June 16, 2010
PubMed

Insights

Macrophage Stimulating Protein (MSP) and its receptor Ron regulate breast cancer growth and metastasis. Targeting this MSP/Ron pathway may offer new therapeutic strategies for breast cancer.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Macrophage Stimulating Protein (MSP) is the sole ligand for the receptor tyrosine kinase Ron.
  • The MSP/Ron pathway influences macrophage activity, wound healing, and epithelial cell behavior.
  • Recent findings implicate the MSP/Ron pathway in regulating breast cancer growth, angiogenesis, and metastasis.

Purpose of the Study:

  • To review the literature on MSP/Ron pathway function in breast tumor microenvironments.
  • To discuss the implications of MSP/Ron activity in coexisting tumor cells, inflammatory cells, and osteoclasts.
  • To explore the therapeutic potential of targeting the MSP/Ron pathway in breast and other cancers.

Main Methods:

  • Literature review of recent studies on the MSP/Ron pathway in cancer.
  • Analysis of MSP/Ron interactions within the tumor microenvironment.
  • Discussion of therapeutic strategies targeting MSP/Ron.

Main Results:

  • The MSP/Ron pathway plays a significant role in tumor cell proliferation, angiogenesis, and metastasis in breast cancer.
  • Concurrent MSP/Ron activity in tumor cells, inflammatory cells, and osteoclasts may impact tumor progression.
  • The MSP/Ron pathway is implicated in the behavior of key cell types within the breast tumor microenvironment.

Conclusions:

  • The MSP/Ron pathway is a critical regulator of breast cancer progression and metastasis.
  • Targeting the MSP/Ron pathway presents a promising therapeutic avenue for breast cancer treatment.
  • Further research into MSP/Ron's role in the tumor microenvironment could uncover novel therapeutic targets for various cancers.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...